
At least five people have been killed in a bomb explosion in a packed mosque in Nigeria's north-eastern Borno state, a police spokesman has said.
Nahum Daso told local media another 35 people were injured in the blast in the Gamboru market of Maiduguri, the state capital, during evening prayers.
Unverified footage on social media appears to show the aftermath of the explosion, with people stood in a market area with dust particles in the air.
No group has admitted carrying out the attack, but militants have previously targeted mosques and crowded places in the area with suicide attacks and improvised explosive devices (IED).
Maiduguri has been central to an insurgency by the militant Islamist group Boko Haram and its offshoot Islamic State West Africa Province.
Military operations by Boko Haram to create an Islamic caliphate in Borno state began in 2009.
Security measures against the group have failed to prevent sporadic attacks against civilians in north-east Nigeria.
LATEST POSTS
- 1
Tire Brands for Senior Drivers: Guaranteeing Security and Solace06.06.2024 - 2
Novartis to build manufacturing hub in North Carolina, creating 700 jobs19.11.2025 - 3
All the eclipses, supermoons, meteor showers and planets to spot in 202631.12.2025 - 4
Astronomers discover never-before-seen celestial object: "Cloud 9"06.01.2026 - 5
When fake data is a good thing – how synthetic data trains AI to solve real problems18.11.2025
These Cities Led Global Jet-Setting In 2025, According To New Data
Figure out how to Detect the Best Rooftop Substitution Choices
Forget 'Outer Banks.' These Gen Z-ers just want to watch 'M*A*S*H*' and 'Gilmore Girls.'
How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there'
Vote in favor of your Number one kind of juice
Figure out how to Team up with Your Auto Crash Legal advisor for Best Outcomes
Russian drone slams into block of flats in deadly wave of strikes across Kyiv
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












